North China Pharmaceutical Company.Ltd (SHA:600812)
China flag China · Delayed Price · Currency is CNY
4.830
-0.130 (-2.62%)
May 20, 2026, 11:29 AM CST

SHA:600812 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8,5109,4888,8709,78010,98120,452
Market Cap Growth
-15.65%6.96%-9.30%-10.94%-46.31%21.87%
Enterprise Value
19,74620,18819,92620,59820,89530,116
Last Close Price
4.965.535.155.666.3611.73
PE Ratio
52.6851.8369.851999.79-1092.06
Forward PE
-40.5340.5340.5340.5340.53
PS Ratio
0.961.030.900.971.051.97
PB Ratio
1.231.381.331.561.762.91
P/TBV Ratio
3.323.813.372.933.014.32
P/FCF Ratio
13.5614.9519.9224.3724.1440.68
P/OCF Ratio
7.268.067.219.5510.9319.47
EV/Sales Ratio
2.242.182.022.041.992.90
EV/EBITDA Ratio
12.8113.3113.7316.1515.5124.60
EV/EBIT Ratio
34.2032.1930.2438.4032.9250.18
EV/FCF Ratio
31.4631.8244.7451.3445.9459.90
Debt / Equity Ratio
1.621.631.721.781.771.96
Debt / EBITDA Ratio
7.297.167.527.887.8110.57
Debt / FCF Ratio
17.9017.6825.7127.7824.2927.40
Net Debt / Equity Ratio
1.421.411.471.621.501.21
Net Debt / EBITDA Ratio
6.616.386.747.976.956.92
Net Debt / FCF Ratio
15.7015.2521.9825.3220.5916.85
Asset Turnover
0.410.430.470.480.460.43
Inventory Turnover
2.532.592.632.692.872.76
Quick Ratio
0.490.450.500.490.490.70
Current Ratio
0.720.660.750.780.720.89
Return on Equity (ROE)
3.36%3.80%3.32%0.79%-10.25%0.50%
Return on Assets (ROA)
1.66%1.83%1.94%1.59%1.72%1.54%
Return on Invested Capital (ROIC)
2.49%2.74%2.78%1.04%4.08%1.08%
Return on Capital Employed (ROCE)
5.80%7.00%6.30%5.00%7.20%5.60%
Earnings Yield
1.89%1.93%1.43%0.05%-6.28%0.09%
FCF Yield
7.38%6.69%5.02%4.10%4.14%2.46%
Dividend Yield
0.60%0.63%0.58%0.18%-0.51%
Payout Ratio
257.31%225.53%369.37%10195.21%-3987.68%
Buyback Yield / Dilution
0.92%0.31%-5.27%4.92%-0.70%-4.96%
Total Shareholder Return
1.53%0.94%-4.69%5.10%-0.70%-4.45%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.